Determinants of neoadjuvant chemotherapy use in muscle-invasive bladder cancer

PURPOSE: Cisplatin-based neoadjuvant chemotherapy (NAC) followed by radical cystectomy (RC) is standard of care for muscle-invasive bladder cancer (MIBC). However, NAC is used in less than 20% of patients with MIBC. Our goal is to investigate factors that contribute to underutilization NAC to facili...

Descripción completa

Detalles Bibliográficos
Autores principales: Carvalho, Filipe LF., Zeymo, Alexander, Egan, Jillian, Kelly, Colleen H., Zheng, Chaoyi, Lynch, John H., Hwang, Jonathan, Stamatakis, Lambros, Krasnow, Ross E., Kowalczyk, Keith J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Urological Association 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329637/
https://www.ncbi.nlm.nih.gov/pubmed/32665995
http://dx.doi.org/10.4111/icu.2020.61.4.390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329637/
https://www.ncbi.nlm.nih.gov/pubmed/32665995
http://dx.doi.org/10.4111/icu.2020.61.4.390

Ejemplares similares